-+ 0.00%
-+ 0.00%
-+ 0.00%

REPLIMUNE EXPECTED TO ANNOUNCE AGREEMENT WITH FDA TO RESUBMIT ITS ADVANCED MELANOMA TREATMENT FOR APPROVAL - WSJ

Reuters·05/29/2026 11:32:37

Please log in to view news